What Drives You?

oncology-icon
We're Cleared To Race

Learn about the QuantideX® qPCR BCR-ABL IS Kit and its FDA 510(k) Clearance.

The First FDA-Cleared BCR-ABL Monitoring Assay
genetics-icon
Gearing Up for AMP16

Stop by booth 1219 to share with others how you and your team win the race to advance patient care.

What Drives You?
cdx-icon
Winning Races

View schedule and details about our 2 Corporate Workshops and 9 posters at AMP.

Attend Our Workshops and Poster Sessions
Spotlight

Workshop: Defining the Standard of Care: FDA-Cleared, Clinically Proven CML Monitoring at the MR 4.7 Level

Wednesday, November 9 from 12:00-12:45 pm

Defining the Standard of Care: FDA-Cleared, Clinically Proven CML Monitoring at the MR 4.7 Level, presented by Christopher D. Watt, M.D., Ph.D. and Bernard F. Andruss, Ph.D.

Spotlight

Workshop: Evaluation of an NGS Assay for Detecting RNA Fusions and Splicing Events in Lung Cancer

Wednesday, November 9 from 2:00-2:45 pm

Evaluation of an NGS Assay for Detecting RNA Fusions and Splicing Events in Lung Cancer, presented by Léon C. van Kempen, Ph.D. and Gary J. Latham, Ph.D.

The Latest from Asuragen

Back To
Top